Please login to the form below
annual results
This page shows the latest annual results news and features for those working in and with pharma, biotech and healthcare.
Novo Nordisk reveals positive results at ADA 2021 for higher-dose Ozempic in type 2 diabetes
The results, presented at the Annual Scientific Sessions of the American Diabetes Association (ADA), showed that the trial met its primary endpoint – patients with an elevated mean baseline HbA1c of ... Novo Nordisk has already submitted a label
Latest news
-
AZ’s Farxiga has no significant benefit for hospitalised COVID-19 patients
AstraZeneca’s (AZ) SGLT-2 inhibitor Farxiga showed no significant benefit for hospitalised COVID-19 patients, according to new detailed results presenting at the annual American College of Cardiology (ACC) meeting. ... Despite being unable to
-
Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
Data presented at the virtual American Association for Cancer Research (AACR) annual meeting showcased results from the CheckMate-816 study, which evaluated Opdivo (nivolumab) plus chemotherapy in patients with early-stage ... Although Merck &Co’s
-
Novartis eyes 2021 regulatory submissions for ‘STAMP’ inhibitor asciminib
CML). The detailed results, presented at the annual American Society of Hematology (ASH) meeting, come from the phase 3 ASCEMBL study. ... There is a clear need in later lines of therapy and, based on these results, we believe asciminib may become an
-
bluebird bio’s beta thalassaemia gene therapy Zynteglo scores promising long-term data
Results presented at annual American Society of Haematology (ASH) meeting. bluebird bio has revealed some long-term data for its gene therapy betibeglogene autotemcel, which is marketed as Zynteglo in the ... bluebird bio announced the new long-term data
-
Revenue growth at Ipsen numbs pain of palovarotene calamity
It hopes to “define next steps for the clinical programme to bring palovarotene to patients as quickly as possible”, according to its annual results statement. ... Rival candidates for FOP are however coming through the pipeline, including
AZ’s Farxiga has no significant benefit for hospitalised COVID-19 patients
Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
Novartis eyes 2021 regulatory submissions for ‘STAMP’ inhibitor asciminib
bluebird bio’s beta thalassaemia gene therapy Zynteglo scores promising long-term data
Revenue growth at Ipsen numbs pain of palovarotene calamity
More from news
Approximately 0 fully matching, plus 43 partially matching documents found.
Latest Intelligence
-
Case study: Logic IBD Nurse Education Day and Recognition Event
to nurses, what nurses needed. Using these insights, Jango developed a bespoke annual meeting event that was strongly educational and promoted patient care, and was also personally and professionally rewarding. ... This annual educational meeting has now
-
Doing more with less: when ‘client-centricity’ matters most
The Edelman Trust Barometer is all about earning trust. We often use our annual survey results to inform client programmes. ... In 2018, results found the most trusted ‘voices. of authority’ to be technical and academic experts.
-
Can value-based healthcare take off and reach for the skies?
Ahmad, speaking at a satellite session at the company’s annual results conference earlier this year, revealed that 10% of hospital Trusts in England have contracts with Novartis which is leading
-
Strategic planning: a state of flux
We see many marketers going through the familiar drill of filling in brand templates and presenting the results at the ‘annual review’- but in some cases it’s simply viewed as
-
Case study: Treatment guidance
The Practical Guide was launched as part of a Takeda sponsored symposium at the British Sarcoma Group’s annual conference. ... launched. Takeda’s KAM team distributed the guide to HCPs throughout the UK and at the British Oncology Pharmacy
Case study: Logic IBD Nurse Education Day and Recognition Event
Doing more with less: when ‘client-centricity’ matters most
Can value-based healthcare take off and reach for the skies?
Strategic planning: a state of flux
Case study: Treatment guidance
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
How to get faster results with digital communication
Everyone is under pressure to deliver results fast, so how can you speed up the positive effects of your e-detailing and multichannel communication?
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Events Executive
-
Depending on Experience
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
-
Digital account director
-
Competitive
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Digital strategist
-
Competitive
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- Live Webinar: Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- Another Landmark Lucid Workiversary
- Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
- Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- EU approves bluebird bio’s CALD gene therapy Skysona
- Onyx Health Launch Creative Studio After Record Year
- BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- This month in 1939: How dead cattle led to the discovery of warfarin
- Recruiting patients for real-world studies – the power of a digital campaign
PMHub
Create Health
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
